NO990621D0 - Farmas°ytisk sammensetning innbefattende koenzym Q10 - Google Patents

Farmas°ytisk sammensetning innbefattende koenzym Q10

Info

Publication number
NO990621D0
NO990621D0 NO990621A NO990621A NO990621D0 NO 990621 D0 NO990621 D0 NO 990621D0 NO 990621 A NO990621 A NO 990621A NO 990621 A NO990621 A NO 990621A NO 990621 D0 NO990621 D0 NO 990621D0
Authority
NO
Norway
Prior art keywords
pharmaceutical composition
composition including
including coenzyme
coenzyme
pharmaceutical
Prior art date
Application number
NO990621A
Other languages
English (en)
Other versions
NO990621L (no
NO324654B1 (no
Inventor
Tatsumasa Mae
Yoshitomo Sakamoto
Souichi Morikawa
Takayuki Hidaka
Original Assignee
Kaneka Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kaneka Corp filed Critical Kaneka Corp
Publication of NO990621L publication Critical patent/NO990621L/no
Publication of NO990621D0 publication Critical patent/NO990621D0/no
Publication of NO324654B1 publication Critical patent/NO324654B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
NO19990621A 1996-08-16 1999-02-10 Farmasoytisk sammensetning innbefattende koenzym Q10 NO324654B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP23472996 1996-08-16
JP17319197A JP3889481B2 (ja) 1996-08-16 1997-06-13 医薬組成物
PCT/JP1997/002845 WO1998007417A1 (fr) 1996-08-16 1997-08-18 Compositions pharmaceutiques contenant de la coenzyme q¿10?

Publications (3)

Publication Number Publication Date
NO990621L NO990621L (no) 1999-02-10
NO990621D0 true NO990621D0 (no) 1999-02-10
NO324654B1 NO324654B1 (no) 2007-11-26

Family

ID=26495272

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19990621A NO324654B1 (no) 1996-08-16 1999-02-10 Farmasoytisk sammensetning innbefattende koenzym Q10

Country Status (12)

Country Link
US (1) US6184255B1 (no)
EP (1) EP0956854B1 (no)
JP (1) JP3889481B2 (no)
CN (1) CN1091368C (no)
AU (1) AU714644B2 (no)
CA (1) CA2263404C (no)
DE (1) DE69726015T2 (no)
DK (1) DK0956854T3 (no)
ES (1) ES2210554T3 (no)
HU (1) HU225266B1 (no)
NO (1) NO324654B1 (no)
WO (1) WO1998007417A1 (no)

Families Citing this family (102)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3926888B2 (ja) * 1997-05-27 2007-06-06 株式会社カネカ コレステロール低下剤
US6616942B1 (en) * 1999-03-29 2003-09-09 Soft Gel Technologies, Inc. Coenzyme Q10 formulation and process methodology for soft gel capsules manufacturing
US6455072B1 (en) * 1999-10-28 2002-09-24 Ingredient Innovations International Stable aqueous dispersion of nutrients
US6617305B1 (en) * 2000-10-10 2003-09-09 Ingredient Innovations Internaitonal Stable aqueous dispersion of nutrients
US8753675B1 (en) * 2000-01-20 2014-06-17 Raj K. Chopra Reduced form of Coenzyme Q in high bioavailability stable dosage forms and related applications
US6740338B1 (en) * 2000-01-20 2004-05-25 Raj K. Chopra Reduced form of Cenzyme Q in high bioavailability stable oral dosage form
NZ509803A (en) * 2000-02-09 2001-08-31 Paul A Treatment of fibromyalgia with ubiquinone 10 and succinic acid
JP2005053923A (ja) * 2000-04-12 2005-03-03 Nisshin Pharma Inc 安定化されたユビデカレノン組成物およびユビデカレノン組成物の安定化方法
EP1285650B1 (en) * 2000-05-09 2016-07-27 Kaneka Corporation Method and compositions for inhibiting arteriosclerosis
ATE402692T1 (de) * 2000-05-09 2008-08-15 Kaneka Corp Dermale zusammenstellungen die als wirkstoff coenzym q enthalten
US6623734B2 (en) * 2000-06-22 2003-09-23 Soft Gel Technologies, Inc. Super absorption coenzyme Q10
DE10046541A1 (de) * 2000-09-19 2002-03-28 Knoll Ag Mechanisch stabile darreichungsformen, enthaltend Ubichinone
US6300377B1 (en) * 2001-02-22 2001-10-09 Raj K. Chopra Coenzyme Q products exhibiting high dissolution qualities
JP3742602B2 (ja) * 2001-05-09 2006-02-08 株式会社カネカ 還元型補酵素ｑの安定な溶液
JP4603192B2 (ja) * 2001-05-10 2010-12-22 株式会社カネカ 毛髪頭皮用組成物
CN100438862C (zh) * 2001-05-10 2008-12-03 钟渊化学工业株式会社 辅酶q作为活性成分的经粘膜给药的组合物
TWI237019B (en) * 2001-07-13 2005-08-01 Kaneka Corp Method of producing reduced coenzyme Q10
TW200604159A (en) * 2001-07-13 2006-02-01 Kaneka Corp Method of producing reduced coenzyme Q10 as oily product
TWI237018B (en) * 2001-07-13 2005-08-01 Kaneka Corp Method of producing reduced coenzyme Q10 crystals
ATE485255T1 (de) * 2001-07-13 2010-11-15 Kaneka Corp Verfahren zum kristallisieren von reduziertem coenzym q10 aus wässriger lösung
TWI310029B (no) * 2001-07-13 2009-05-21 Kaneka Corp
TWI235146B (en) 2001-07-16 2005-07-01 Kaneka Corp Method of stabilizing reduced coenzyme q10 and method of acidic crystallization
US20030044474A1 (en) * 2001-08-03 2003-03-06 Shaklee Corporation High molecular weight, lipophilic, orally ingestible bioactive agents in formulations having improved bioavailability
TWI329510B (en) 2001-10-10 2010-09-01 Kaneka Corp Method of stabilizing reduced coenzyme q10
JP3822479B2 (ja) * 2001-10-10 2006-09-20 株式会社カネカ 還元型補酵素ｑ水溶液の安定化組成
TWI329513B (en) * 2001-10-12 2010-09-01 Kaneka Corp Use of reduced coenzyme q for lessening oxidative stress
US6652891B2 (en) 2001-12-12 2003-11-25 Herbasway Laboratories, Llc Co-enzyme Q10 dietary supplement
TWI349039B (en) 2001-12-27 2011-09-21 Kaneka Corp Processes for producing coenzyme q10
TW200302054A (en) * 2002-01-18 2003-08-01 Kaneka Corp Ubiquinone-enriched foods
TW200302056A (en) 2002-01-18 2003-08-01 Kaneka Corp Method for stabilizing reduced coenzyme Q10 and composition therefor
TW200302055A (en) * 2002-01-18 2003-08-01 Kaneka Corp Ubiquinol-enriched fat-containing foods
TW200304372A (en) * 2002-03-20 2003-10-01 Kanegafuchi Chemical Ind Compositions for diabetes
JP4426832B2 (ja) 2002-12-03 2010-03-03 株式会社分子生理化学研究所 コエンザイムｑ−１０及びその２電子還元体の分析方法
DE10301673A1 (de) * 2003-01-17 2004-08-05 Siemens Ag Spannungsversorgungsschaltung sowie Kommunikationsanlage mit Spannungsversorgungsschaltung
TWI322008B (en) * 2003-01-31 2010-03-21 Kaneka Corp Fatigue improving agent including reduced coenzyme q10
US20080089877A1 (en) * 2003-08-14 2008-04-17 Udell Ronald G Super Absorption Coenzyme Q10
US7358402B2 (en) 2003-09-10 2008-04-15 Kaneka Corporation Reduced coenzyme Q10 crystal with excellent stability and composition containing said reduced coenzyme Q10 crystal
US8124072B2 (en) 2003-09-29 2012-02-28 Soft Gel Technologies, Inc. Solubilized CoQ-10
US8105583B2 (en) * 2003-09-29 2012-01-31 Soft Gel Technologies, Inc. Solubilized CoQ-10
US7169385B2 (en) * 2003-09-29 2007-01-30 Ronald G. Udell Solubilized CoQ-10 and carnitine
TW200524579A (en) * 2003-11-28 2005-08-01 Kaneka Corp Composition for protecting liver functions
US20050154066A1 (en) * 2004-01-08 2005-07-14 Kaneka Corporation Antiaging composition
CN100391447C (zh) * 2004-01-15 2008-06-04 范敏华 一种辅酶q10冻干粉针剂及其制备方法
US7708990B2 (en) 2004-03-23 2010-05-04 Kaneka Corporation Coenzyme Q compositions persisting in blood
WO2005089740A1 (ja) * 2004-03-23 2005-09-29 Kaneka Corporation 血中持続性補酵素ｑ組成物
TW200603786A (en) * 2004-05-11 2006-02-01 Kaneka Corp Anti-fatigue composition
JP2006070016A (ja) * 2004-08-02 2006-03-16 Kaneka Corp 還元型補酵素ｑを含有する美白用組成物
WO2006075502A1 (ja) * 2004-12-24 2006-07-20 Kaneka Corporation 還元型補酵素ｑ１０を含有する固形製剤及びその製造方法
US20060147542A1 (en) * 2004-12-24 2006-07-06 Tadao Ono Solid preparation containing reduced coenzyme Q10 and method for producing the same
US8067217B2 (en) 2004-12-28 2011-11-29 Kaneka Corporation Method for preserving reduced coenzyme Q10
WO2006091010A1 (en) * 2005-02-26 2006-08-31 Eotech Co., Ltd Composition comprising coenzyme q10 as effective ingredient
AU2006219823A1 (en) * 2005-03-02 2006-09-08 Metanomics Gmbh Process for the production of fine chemicals
TW200722077A (en) * 2005-03-29 2007-06-16 Kaneka Corp Composition for enhancing expression and activity of protease in liver
WO2006104153A1 (ja) * 2005-03-29 2006-10-05 Kaneka Corporation 血液中の抗酸化活性を高める組成物
US10532028B2 (en) * 2005-07-28 2020-01-14 Isp Investments Llc Method to improve characteristics of spray dried powders and granulated materials, and the products thereby produced
US8506956B2 (en) 2005-10-31 2013-08-13 Kaneka Corporation Method for stabilizing reduced coenzyme Q10
US20090081683A1 (en) * 2005-11-29 2009-03-26 Genelink, Inc. Kits and Methods for Assessing the Coenzyme Q Reducing Status of a Patient, Including a Patient Ingesting a Statin
US20070184040A1 (en) * 2006-02-06 2007-08-09 Clouatre Dallas L Compositions for delivery of coenzyme Q10
JP5103374B2 (ja) * 2006-03-13 2012-12-19 株式会社カネカ 心機能不良改善剤または心機能維持剤
JPWO2007119578A1 (ja) * 2006-03-29 2009-08-27 株式会社カネカ 神経系細胞機能改善剤
WO2007126086A1 (ja) 2006-04-28 2007-11-08 Kaneka Corporation 還元型補酵素ｑ10の精製方法
JP5286081B2 (ja) 2006-04-28 2013-09-11 株式会社カネカ 還元型補酵素ｑ１０の安定化方法
AU2007261943B2 (en) 2006-06-22 2012-11-01 Kaneka Corporation Reduced coenzyme Q10-containing composition and method for producing the same
US8642030B2 (en) * 2006-08-25 2014-02-04 Epc Europe Gmbh Compositions containing coenzyme Q-10 and dihydrolipoic acid
JP5286086B2 (ja) * 2006-09-08 2013-09-11 株式会社カネカ 還元型補酵素ｑ１０及びリゾレシチンを含有する組成物
BRPI0605162A (pt) * 2006-10-19 2008-06-10 Bunge Alimentos S A óleo de natureza triglicerìdica com propriedades nutricionais melhoradas e processo para preparação do mesmo
WO2008076780A2 (en) * 2006-12-14 2008-06-26 Isp Investments Inc. Amorphous valsartan and the production thereof
WO2008080037A2 (en) * 2006-12-21 2008-07-03 Isp Investments Inc. Carotenoids of enhanced bioavailability
WO2008092057A2 (en) * 2007-01-26 2008-07-31 Isp Investments Inc. Formulation process method to produce spray dried products
WO2008092046A2 (en) * 2007-01-26 2008-07-31 Isp Investments Inc. Amorphous oxcarbazepine and the production thereof
US8343541B2 (en) 2007-03-15 2013-01-01 Soft Gel Technologies, Inc. Ubiquinol and alpha lipoic acid compositions
WO2008156108A1 (ja) * 2007-06-21 2008-12-24 Kaneka Corporation 機能性家畜生産品およびその製造方法
US20110123505A1 (en) 2007-08-22 2011-05-26 Kaneka Corporation Method of producing reduced coenzyme q10 and method of stabilizing the same
WO2009025372A1 (ja) * 2007-08-23 2009-02-26 Kaneka Corporation 還元型補酵素ｑ１０含有組成物及びその安定化方法
KR100790957B1 (ko) 2007-09-06 2008-01-04 영남대학교 산학협력단 코-엔자임 ｑ 경구용 고형제제 조성물
JP5558823B2 (ja) * 2007-10-05 2014-07-23 株式会社カネカ 還元型補酵素ｑ１０の製造方法
CN101842340B (zh) 2007-10-30 2014-08-13 株式会社钟化 使用含水有机溶剂制备还原型辅酶q10的方法
JP2009179576A (ja) * 2008-01-30 2009-08-13 Kaneka Corp Ｑｏｌ改善剤
EP2268160B1 (en) 2008-03-20 2012-12-05 Virun, Inc. Emulsions including a peg-derivative of tocopherol
CN102131407B (zh) * 2008-06-23 2015-01-07 维尔恩公司 含有非极性化合物的组合物
US8263094B2 (en) * 2008-09-23 2012-09-11 Eastman Chemical Company Esters of 4,5-disubstituted-oxy-2-methyl-3,6-dioxo-cyclohexa-1,4-dienyl alkyl acids and preparation thereof
IT1391654B1 (it) * 2008-11-07 2012-01-17 Tarullo Prodotto alimentare a base di olio extra vergine di oliva
CN102656134A (zh) 2009-10-16 2012-09-05 株式会社钟化 还原型辅酶q10的制造方法、稳定化方法以及含有还原型辅酶q10的组合物
CA2792330C (en) 2010-03-23 2017-01-03 Virun, Inc Nanoemulsion including a peg-derivative of vitamin e and a sucrose fatty acid ester
WO2011162802A1 (en) 2010-06-21 2011-12-29 Virun, Inc. Compositions containing non-polar compounds
DK2725004T3 (en) 2011-06-24 2018-04-16 Kaneka Corp REDUCED COENZYM Q10 CRYSTAL WITH EXCELLENT STABILITY
US9149528B2 (en) 2011-10-13 2015-10-06 Premier Dental Products Company Topical vitamin D oral supplement compositions
EP2811847B1 (en) 2012-02-10 2017-12-13 Virun, Inc. Beverage compositions containing non-polar compounds
JP2015131766A (ja) 2012-04-27 2015-07-23 株式会社カネカ 還元型補酵素ｑ１０の製造方法
US9877930B2 (en) 2012-10-12 2018-01-30 Premier Dental Products Company Topical ubiquinol oral supplement compositions with amorphous calcium phosphate
US9724542B2 (en) 2012-10-12 2017-08-08 Premier Dental Products Company Remineralizing and desensitizing compositions, treatments and methods of manufacture
US9351517B2 (en) 2013-03-15 2016-05-31 Virun, Inc. Formulations of water-soluble derivatives of vitamin E and compositions containing same
CN103601622B (zh) * 2013-11-29 2016-08-17 厦门金达威集团股份有限公司 还原型辅酶q10的制备方法
US10016363B2 (en) 2014-09-18 2018-07-10 Virun, Inc. Pre-spray emulsions and powders containing non-polar compounds
US9861611B2 (en) 2014-09-18 2018-01-09 Virun, Inc. Formulations of water-soluble derivatives of vitamin E and soft gel compositions, concentrates and powders containing same
CN107773550A (zh) * 2016-08-26 2018-03-09 康普药业股份有限公司 一种辅酶ｑ10胶囊及其制备方法
CN106617028A (zh) * 2016-12-02 2017-05-10 芜湖市诺康生物科技有限公司 一种辅酶q10胶囊及其制备方法
WO2020045571A1 (ja) 2018-08-30 2020-03-05 株式会社カネカ 安定性に優れた還元型補酵素ｑ１０結晶の製造方法
CN113166017B (zh) * 2018-09-28 2024-03-29 株式会社钟化 稳定性优异的还原型辅酶q10结晶的制造方法
US11471426B2 (en) 2019-10-16 2022-10-18 American River Nutrition, Llc Compositions comprising quinone and/or quinol and methods of preparations and use thereof
US20230339836A1 (en) 2020-02-12 2023-10-26 Kaneka Corporation Method for producing reduced coenzyme q10 form ii crystals
JPWO2022202215A1 (no) 2021-03-26 2022-09-29

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL127780C (no) * 1959-10-09
JPS5947202A (ja) 1982-09-10 1984-03-16 Zeria Shinyaku Kogyo Kk 補酵素Ｑ↓１↓０のメチル化−β−シクロデキストリン包接体及びその製造方法
JPH0637388B2 (ja) 1986-02-17 1994-05-18 千寿製薬株式会社 水性液剤
JP2852555B2 (ja) 1990-07-27 1999-02-03 塩野義製薬株式会社 新規な水溶性ビタミンｋ類誘導体およびその製造法
US5312819A (en) * 1990-08-20 1994-05-17 Sandoz Ltd. Pharmaceutical compositions comprising clozapine and a radical scavenger
US5648377A (en) * 1993-12-21 1997-07-15 Indena S.P.A. Formulations containing carotenoids an procarotenoids combined with polyphenols in the prevention of the damages due to an abnormal production of free radicals
AU4510596A (en) * 1994-12-06 1996-06-26 National Research Council Of Canada Water soluble ubiquinone compositions, prodrugs, and methods relating thereto

Also Published As

Publication number Publication date
WO1998007417A1 (fr) 1998-02-26
HUP9903174A3 (en) 2000-07-28
NO990621L (no) 1999-02-10
ES2210554T3 (es) 2004-07-01
AU3865497A (en) 1998-03-06
HUP9903174A2 (hu) 2000-04-28
CN1226823A (zh) 1999-08-25
EP0956854A4 (en) 2002-10-16
CA2263404A1 (en) 1998-02-26
JPH10109933A (ja) 1998-04-28
EP0956854A1 (en) 1999-11-17
EP0956854B1 (en) 2003-11-05
NO324654B1 (no) 2007-11-26
US6184255B1 (en) 2001-02-06
DE69726015D1 (de) 2003-12-11
DE69726015T2 (de) 2004-08-19
DK0956854T3 (da) 2004-02-09
HU225266B1 (en) 2006-08-28
JP3889481B2 (ja) 2007-03-07
AU714644B2 (en) 2000-01-06
CA2263404C (en) 2006-06-20
CN1091368C (zh) 2002-09-25

Similar Documents

Publication Publication Date Title
NO990621D0 (no) Farmas°ytisk sammensetning innbefattende koenzym Q10
ID22891A (id) Komposisi farmasi untuk kombinasi piperidinoalkanol-dekongestan
ID27415A (id) Komposisi farmaseutik
IS4974A (is) Lyfjasamsetning á þrýstingsúðaformi
NO20005913D0 (no) Legemiddelsammensetning
ID16038A (id) Komposisi farmasi untuk imunomodulasi
IL122447A0 (en) Pharmaceutical composition with anaestheric effect
GB9706089D0 (en) Pharmaceutical composition
ID18352A (id) Komposisi-komposisi farmasi
ID29262A (id) Komposisi farmasi
ID27201A (id) Komposisi farmasi
ID27150A (id) Sediaan levotiroksin bahan farmasi
ID16781A (id) Formulasi-formulasi farmasi
ID29294A (id) Komposisi farmasi
BR9507768A (pt) Composição farmacêutica
NO992724D0 (no) Farmas°ytiske blandinger inneholdende N-sulfonyl-indolin-derivater
GB9717428D0 (en) Pharmaceutical composition
ID18698A (id) Komposisi farmasi
ID25857A (id) Komposisi farmasi
ID26215A (id) Komposisi farmasi
ITMI962628A0 (it) Composizione farmaceutica
ID23531A (id) Komposisi farmasi
GB2321190B (en) Pharmaceutical composition
SE9601854D0 (sv) Farmaceutisk komposition
ID17133A (id) Komposisi farmasi

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees